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Despite the increasing prevalence of anaphylaxis, there is little information about the 
characteristics and practice of healthcare providers in treating anaphylaxis, so this study was 
conducted to record the characteristics and therapeutic approaches of anaphylaxis from May 
2012 until April 2015, the data of all patients diagnosed with anaphylaxis in the Allergy 
department of three referral university hospitals in Tehran, Iran were recorded. Thereafter, 
the demographics, clinical features, triggers and therapeutic approach were evaluated.  
This study investigated 136 individuals, 64 males (47%) between 6 months and 68 years 
old, as well as 72 others (52.94%) under 18 years of age (pediatric). The following were the 
most common organs involved: Skin 86.02% (pediatric 91.66% vs adult 79.68%), respiratory 
tract 51.47% (pediatric 43.05% vs adult 60.93%), cardiovascular 50.73% (pediatric 54.16% vs 
adult 46.87%), gastrointestinal 20.58% (pediatric 27.7% vs adult 12.5%) and neurologic 
system 5.88% (only in adults). The following were the most identified causing foods 69 
(50.37%) [42 pediatric (children) and 27 adults], drugs 34(25%)[14 pediatric and 20 adults], 
idiopathic 16(11.77%) [3 pediatric and 13 adults], insect sting 7(5.15%) [3 pediatric and 4 
adults], exercise 6(4.42%) [1 pediatric and 5 adults]. Milk, egg and wheat were the most 
common causative foods in pediatric cases but sesame, as well as egg and milk were the most 
common causes in adults. Epinephrine injection, auto injector epinephrine prescription as a 
discharging plan and referral to an allergist were: 10.78, 1.96 and 7.8 %, respectively. 
In this case series we found that, cutaneous, respiratory, cardiovascular and 
gastrointestinal complains were the most common manifestations and food, drug and 
idiopathic were the most common causes. 
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In this study, the diagnosis of anaphylaxis, epinephrine subscription and referral to an 
allergist were significantly lower in comparison to other studies. 
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Anaphylaxis is defined as a systemic, rapid onset and 
potentially life-threatening hypersensitivity reaction. It is 
a clinical emergency so all healthcare providers should 
be familiar with its management.
1-4
 The diagnosis of 
anaphylaxis is based on history and physical exam and it 
is very critical considering that there is a broad spectrum 
of presentations and shock is just an uncommon 
manifestation in anaphylaxis and relying on it can result 
in the under diagnosis of anaphylaxis.
5,6
 Defining the 
exact prevalence of anaphylaxis is difficult and it seems 
that there is under diagnosis and consequently, under 
correct treatment of this condition. However, on the 
other hand, based on literature, the prevalence and 
incidence of anaphylaxis is increasing all over the 
world.
7-9
 There are different reasons for the potential 
fatality of anaphylaxis including similarity with other 
diseases, under estimating the condition in parallel with 
the delay and under usage of epinephrine.
10-12 
Different 
barriers have been determined in literature as the main 
reasons for malpractice in anaphylaxis. Correct and rapid 
diagnosis, epinephrine injection in the first line and 
having a correct discharging plan are the main steps in 
managing anaphylaxis.
6,10,13
 In the first step, this 
retrospective study was conducted in all individuals 
diagnosed with anaphylaxis by an allergist in the allergy 
department of three referral university hospitals between 
2012-2015. In this study, the following were recorded 
clinical manifestations, causative trigger and treatment 
approach during attacks and discharging plans in the 
acute phase and the recurrence of attacks before and after 
visiting an allergist and determining the causative 
etiology. This study was approved by the ethical board in 
Iran University of Medical Sciences. 
 
MATERIALS AND METHODS 
 
This retrospective study was performed and included 
all patients who came to the outpatient clinic of the 
Allergy department in 3 referral university hospitals: 
Rasool e Akram, Ali Asghar and Firoozabadi, affiliated  
 
to Iran University of Medical Sciences from May 2012 
until April 2015. Individuals diagnosed with anaphylaxis 
were selected based on anaphylaxis criteria by an 
allergist and accepted to be investigated. The study was 
approved by Research Ethics Committee of Iran 
university of Medical sciences with approval number: 
96/105/546 and all participants provided written 
informed consent. Data were collected using a standard 
questionnaire which focused on these items: (1) 
demographic data; (2) atopic status of the patient and the 
family; (3) the symptoms of anaphylactic event, (4) the 
course of anaphylaxis including the time lapse between 
contact with the trigger and onset of symptoms, the first 
symptom of the reaction, total duration of symptoms, 
and being biphasic or not; (5) the treatment: drugs and 
admission; (6) discharging plan including: action plan, 
referral to an allergist, epinephrine prescription, (7) 
recurrence before and after visiting the allergist, and (8) 
the causative trigger of anaphylaxis.  
 
Determining the Etiology 
The discovery that food, insect bites or drugs are the 
causative trigger for anaphylaxis was based on a clear 
and relative history of anaphylaxis onset within hours 
after exposure to the causative agent, skin prick testing 
and/or in some cases by serum specific IgE (sIgE) 
testing (Phadia250 Detection System, ImmunoCAP, 
Phadia AB, Sweden). Serum sIgE levels >0.35 kU/L 
were considered positive and skin prick testing was 
performed based on approved methods in the allergy 
clinic.
14
 Idiopathic anaphylaxis was diagnosed if the 
medical history did not suggest a clear trigger and all 
allergen tests were negative. As a result of the potential 
risks of triggering anaphylaxis with oral challenges, oral 
food or drug challenges were not performed. 
 
Statistical Analysis  
All analyses were performed using SPSS software 
version 10.0 (SPSS Inc., Chicago, IL, USA).  
A descriptive analysis was used for the 
demographics of the study group. Non-parametric 
variables were analyzed with the Pearson chi-square 
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test or the Fisher’s exact test when needed. The 
Wilcoxon-Mann-Whitney U test and Kruskal-Wallis 
one-way ANOVA were used to compare age, time 
lapse between contact with the trigger and onset of 
symptoms, time lapse between the onset of symptoms 
and administration of medications, and the total 




Demographic Characteristics  
This case series consisted of 136 individuals who 
were aged between 6 months and 68 years 
(21.01±15.26 years), 64 males (47%) with no 
difference between sexes (p>0.05). The demographic 
data and allergy history are explained below (Table 1). 
 
Timing 
In 46 (33.82%) cases, anaphylaxis happened less 
than 5 min (very rapid attack) after exposure to the 
causative agent and it was significantly more prevalent 
in children (p<0.05). Attacks happened between 5-60 
min (rapid attack), after exposure in 38 individuals 
(27.94%) without difference in children and adults 
(p>0.05) and in 32 (23.52%) of them attacks happened 
after 1 hour (delayed attack) with more significant 
prevalence in adults (p<0.05), 20 patients were not 
oriented to the onset of attack and biphasic reactions 
were presented in 6 patients (4.41%). 
 
Organ Involvement 
The following were the most prevalent organs 
involved: Skin (86.02%), respiratory organ (51.47%), 
cardiovascular (50.73%), gastrointestinal tract 
(20.58%) and neurologic system (5.88%). GI 
involvement was significantly (p<0.05) more prevalent 
in pediatrics while neurologic manifestation was only 
seen in adults, vaginal bleeding occurred in 3 adult 
females. The manifestations are shown in Table 2. 
 
Etiology 
In 87 of the 136 participants (63.97%), the patients' 
suggestions about the cause of their anaphylaxis were 
correct but 49 of them (36.02%) could not determine if 
their suggestion was wrong. Food (50.73%), drug 
(25%), idiopathic (11.76%), insect sting (5.14%) and 
exercise (4.41%) were the most common culprits in our 
case series. Milk (n=17), egg (n=9) and wheat (n=9) 
were the most causative foods in pediatric but egg 
Table 1. Demographics and allergy history in 
anaphylactic patients  
Characteristics N (%) 
Adult (>18y) 64(47.05%) 
Pediatric (<18y) 72(52.95%) 
Male 64(47%) 
Female 72 (53%) 
Personal allergy history 
Food allergy 40 (29.4%) 
Allergic rhinitis 39(28.67%) 
Asthma 36(26.47%) 
Atopic dermatitis 34(25%) 
Urticarial &angioedema 23(16.91%) 
Drug allergy 13(9.55%) 
Clinical presentations 
 
(n=6), sesame (n=6) and milk (n=5) were more (n=6), 
sesame (n=6) and milk (n=5) were more prevalent in 
adults. NSAIDs, antibiotics and anticonvulsants were 
the most causative drugs but NSAIDs were more 
prevalent in adult cases while antibiotics were more 
prevalent in pediatrics. Three of our patients 
experienced food dependent and exercise induced 
anaphylaxis, one pediatric with wheat and two adults 
with shrimp and pistachio (Table 3). 
 
Recurrence Rate 
A total of 51 (37.5%) individuals experienced one 
anaphylactic attack but 85(62.5%) experienced more 
than one attack. In total, 226 cases of anaphylaxis were 
documented in these 85 individuals. In 8 individuals, 
the second attack occurred less than one month, 33 
individuals between 1month and one year and 44 
individuals could not remember the exact time of the 
second attack. 
The most common causes of repeated anaphylaxis 
were food (n=50), idiopathic (n=13), drug (n=11), 
exercise (n=6) and venom sting (n=5). It was only in 
one case that the second anaphylaxis trigger differed 
from the first episode. The rate of anaphylaxis 
recurrence was significantly higher (p<0.05) before 
visiting an allergist and determining the causative 
etiology, as 64 of 85 individuals experienced 165 
anaphylaxis before visiting and 21 of them had 61 
attacks after determining the cause by an allergist. In 
the group which was alert to their diagnosis and its 
trigger; food (n=9), idiopathic (n=8), drug (n=2) and 
venom sting (n=2) were the most causes and they were 
unavoidable, hence their orientation. 
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Treatment 
A total of 102 of 136 individuals visited emergency 
departments during the symptomatic phase but 34 of 
them did not go during attacks, from 102 patients 25 
individuals were admitted (24.5%) more than 4 hours, 33 
individuals were admitted less than 4 hours (32.35%) 
and 44 individuals were quickly discharged soon after 
visit (43.13%). H1 anti-histamines followed by systemic 
corticosteroids were the most common prescription in 
symptomatic individuals; epinephrine was prescribed in 
11 individuals (10.78%). As a discharging plan, auto 
injection of epinephrine was prescribed in 2 individuals 
(1.96%) and 8 of them were referred to an allergist 
(7.8%). Treatment is shown in Table 4. 
 
Table 2. Organ involvement in anaphylactic patients 
Organ involvement Pediatric: n (%) Adult: n (%) Total: n (%) 
Patients 72 (52.94%) 64 (47.05%) 136 (100%) 
Skin 66 (91%) 51 (79.98%) 117 (86.02%) 
Respiratory                        31 (43.05%) 39 (60.93%) 70 (51.47%) 
Gastrointestinal 20 (27.77%) 8 (12.5%) 28 (20.58%) 
Cardio vascular 39 (54.16%) 30 (46.87%) 69 (50.73%) 
Neurologic system 0 (0%) 8 (12.5%) 8 (5.88%) 
Others:    
Vaginal bleeding 0 (0%) 3 (4.68%) 3 (2.2%) 
 
Table 3. Causative factors in pediatric and adult anaphylaxis 
Cause Pediatric: n (%) Adult: n (%) Total: n (%) 
Patient 72 (52.94%) 64 (47.05%) 136 
Food 42 (58.33%) 27 (42.18%) 69 (50.73%) 
Milk 17 (23.61%) 5 (7.81%) 22 (16.17%) 
Egg 9 (12.5%) 6 (9.37%) 15 (11.02%) 
Wheat 9 (12.5%) 2 (3.12%) 11 (8.08%) 
Sesame 1 (1.38%) 6 (9.37%) 7 (5.14%) 
Hazelnut 2 (2.77%) 3 (4.68%) 5 (3.67%) 
Almond 1 (1.38%) 0 (0%) 1 (0.73%) 
Peanut 2 (2.77%) 1 (1.56%) 3 (2.2%) 
Peach 0 (0%) 2 (3.12%) 2 (1.47%) 
Saffron 0 (0%) 2 (3.12%) 2 (1.47%) 
 Kiwi 1 (1.38%) 0 (0%) 1 (0.73%) 
Drug 14 (19.44%) 20 (31.25%) 34 (25%) 
 Penicillin 3 (4.16%) 5 (7.81%) 8 (5.88%) 
 Ceftriaxone 0 (%) 2 (3.12%) 2 (1.47%) 
 Co-trimoxazol 2 (2.77%) 1 (1.56%) 3 (2.2%) 
 NSAIDs 0 (0%) 14 (21.87%) 14 (19.04%) 
 Phenobarbital 3 (4.16%) 1 (1.56%) 4 (2.94%) 
 Lamotrigine 2 (2.77%) 0 (0%) 2 (1.47%) 
 Losartan 0(0%) 1 (1.56%) 1 (0.73%) 
Idiopathic 3 (4.16%) 13 (20.31%) 16 (11.76%) 
*Exercise 1 (1.38%) 5 (7.81%) 6 (4.41%) 
Venom sting 3 (4.16%) 4 (6.25%) 7 (5.14%) 
**Vaccine 3 (4.16%) 0 (0%) 3 (2.2%) 
Latex 0 (0%) 1 (1.56%) 1 (0.73%) 
*3 of them were food dependent exercise induced anaphylaxis (one pediatric and two adult) 
**all of them were due to MMR vaccine (mumps, measles and rubella) 
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Table 4. Treatment and discharging plan in anaphylactic patients 
Information about treatment and discharging plan Number (percent) 
No emergency department (ED) visit during symptomatic phase 34 (25%) 
 ED Visit during symptomatic phase 102 (75%) 
 Early discharge just after visit 44/102 (43.13%) 
 Admitted but discharged before 4 hours 33/102 (32.35%) 
 Admitted and discharged after 4 hours 25/102 (24.5%) 
 Drugs prescribed in ED   
 Systemic H1 anti histamine 98 (96.07%) 
 Systemic corticosteroids 79 (77.45%) 
 Epinephrine 11 (10.78%) 
 Discharged with correct diagnosis of anaphylaxis 6/102 (5.88%) 
 Refering to allergist after discharging 8/102 (7.84%) 





This retrospective study registered the 
characteristics, causative etiology and therapeutic 
approach with special attention to discharging plan in 
pediatric and adult anaphylaxis, visited and diagnosed 
in allergy clinics of three tertiary university hospitals in 
Tehran, the capital city of Iran. To our knowledge, this 
is the largest investigation concerning the etiology in 
adult population and the first study that recorded the 
treatment and discharging plan for anaphylaxis in Iran. 
Hsin YC showed that anaphylaxis is more common in 
adults than children (pediatric) and more common in 
males than females in Taiwan, and atopic dermatitis 
was the most prevalent allergy history especially in 
pediatrics.
15
 Blackhall study in Tasmania, Australia, 
showed that anaphylaxis is more prevalent in adults 
(78.91%) vs children (21.1%) and in the adult age was 
more prevalent in females but in pediatric cases, it was 
more prevalent in males.
16
 Our investigation showed 
that anaphylaxis was more prevalent in children 
(52.94%) than adults (47.06%) and females (53%) than 
males (47%); however, the p value was not significant 
(p>0.05). Personal and familial history of allergy was 
positive in 75.73 and 69.85% of individuals. A personal 
history of food allergy (29.4%) was the most common 
while drug allergy (9.55%) was the least common 
finding in the allergy history. It appears that the 
prevalence of anaphylaxis and distribution according to 
sex and age is dependent on the study area, duration 
and inclusion criteria. Since our study was limited to 3 
referral hospitals, with one of them being a pediatric 
hospital, so maybe this is the reason for more 
prevalence in pediatrics. Based on previous studies, the 
causes of anaphylaxis vary based on the geographical 
location and subject selection. In the first children 
anaphylaxis registry in Iran, food was reported as the 
most common cause (89.7%) of anaphylaxis in the 
children population; of which milk (49.3%) and wheat 
(26.1%) were the most common foods followed by 
insect sting (4.3%),
17 
this study was limited to pediatric 
field and only focused to the etiology and manifestation 
while our study enrolled children and adult data and 
focused on management in addition to manifestation. A 
study of patients from an outpatient allergy clinic in 
Central Europe showed that insect bites were the most 
common cause of anaphylaxis,
18
 while in South Korea, 
emergency patients reported drugs as the most common 
cause.
19
 A study based on two nationwide surveys 
showed that the most common triggers of anaphylaxis 
in the American population were medications (34%), 
foods (31%), and insect stings (20%).
20
 However, Jiang 
et al showed that foods are the most common cause 
(77%), followed by idiopathic factors (15%), 
medications (7%) and insects (0.6%) in a tertiary center 
in China and milk is the most common trigger in 
pediatrics followed by fruits and vegetables and wheat 
as the most common trigger in adults. In a previous 
study, 7% of anaphylactic reactions was triggered by 
drugs in which herbs were the most common followed 
by antibiotics.
21
 In our study, the most common 
causative triggers in children and adults were foods 
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(pediatric 58.33% vs adult 42.18%, p>0.05), drug 
(pediatrics 19.44% vs 31.25, p<0.05), idiopathic 
(pediatric 4.16% vs adult 20.31%, p<0.05) and sting 
(pediatric 4.16% vs adult 6.25%, p>0.05). In 
comparison to studies from other countries, unique 
patterns of food-induced anaphylaxis were observed for 
Iranian adult patients. In adults, sesame (22.22%), egg 
(22.22%), milk (18.51%), hazelnut (11.11%) and 
saffron (7.4%) were the most common triggers, 
respectively. To our knowledge, such a high proportion 
of some foods has not yet been reported in Western 
countries, which may be related to the different life 
styles and different food consumption. For example, 
sesame is used in large amounts in different foods in 
Iran and saffron is one of the most common additives 
used in Iran. In contrast to North American countries 
where peanut was an important trigger,
22,23
 in our study 
hazelnut was more common than peanut, however 
neither hazelnut nor peanut were common triggers. The 
recurrence of anaphylaxis is not an unusual problem 
and this makes it more complex. It is estimated that 
one-third of cases present with recurrent anaphylaxis.
24
 
It appears that there are many reasons for the 
recurrence of anaphylaxis including: incorrect or 
delayed diagnosis of anaphylaxis, incorrect 
determination of the causative etiology, cross reactivity 
between causes and incidental exposures to the 
cause.
25,26
 There is insufficient data about recurrent 
anaphylaxis, especially when mast cell disorders are 
excluded.
27-29
 Based on the literature, all patients with 
anaphylaxis do not have the same risk of recurrence. 
Patients with drug anaphylaxis have a lower risk
30
 but 
in exercise-induced, idiopathic and food anaphylaxis 
the chance is increased.
25,30-32
 It seems that the etiology 
of recurrent anaphylaxis is dependent on the 
geographic area and the age of patients included for 
investigation. For example, in some areas, venom 
stings are the main cause of recurrence
33,34
 but O’Keefe 
et al showed that food is the main culprit responsible 
for recurrent anaphylaxis in children in Canada.
25
 To 
the best of our knowledge, this study is the only 
investigation that has focused on this problem in Iran. 
Records were taken before and after visiting the 
allergist. Our study showed that confirming the 
diagnosis and determining the etiology, significantly 
(p<0.05) decreased the rate of anaphylaxis attacks in 
cases with recurrent anaphylaxis. However, in 61 of 85 
cases with repeated anaphylaxis, the attack happened 
despite documenting the diagnosis and finding out the 
trigger. So, according to our study, the rate of 
anaphylaxis will decrease after referral to the allergist 
but it is not totally avoidable especially in the case of 
food, idiopathic causes, exercise and venom sting 
anaphylaxis. In all ages, epinephrine is the most 
important drug recommended in anaphylaxis and it is 
strongly advised to inject it rapidly after diagnosis.
2,5,35-
37
 Despite practical guidelines in the field of 
anaphylaxis, it seems that the approach of healthcare 
providers to anaphylaxis management is not optimum 
in different countries. In a global survey of 52 
countries, World Allergy Organization showed that 
anaphylaxis guideline and essential drugs, especially 
epinephrine in emergency settings, are available only in 
31 of the 52 countries which participated in this 
investigation.
38
 Most mans et al showed that the ED 
physicians in the St. Pierre hospital in Brussels used 
epinephrine in 67% of anaphylaxis and referred 74% of 
their cases to the allergist after discharging from the 
ED.
39
 Epinephrine injection in ED, auto-injection 
epinephrine prescription as a discharging plan and 
referral to the allergist for further evaluation were 47, 
61 and 45%, respectively, in Arkansas children 
hospital.
40
 It was found that the Epinephrine injection 
rate in anaphylaxis is not optimum in all countries. 
Abdullah et al showed that epinephrine prescription 
and referral to the allergist were 3.2 and 16% in 
Riyadh, Saudi Arabia.
41
 Also, there was 15.9% 
epinephrine injection in anaphylaxis attack and 4.5% 
auto-injection of epinephrine prescription as 
discharging plan in Lebanon.
42
 In our study, 102 of 136 
individuals with anaphylaxis went to ED during their 
acute phase. In these cases, epinephrine injection in 
ED, auto-injection of epinephrine prescription and 
referral to the allergist were: 10.78, 1.96 and 7.8%, 
respectively. It seems that there is a significant under 
prescription of epinephrine in the management of 
anaphylaxis in our hospitals. 
This study showed that: skin, cardiovascular and 
respiratory systems were the most commonly involved 
organs in pediatric anaphylaxis as: 91.66, 54.16 and 
43.05%, respectively but skin, respiratory and 
cardiovascular were: 79.68, 60.93 and 46.87 % in 
adults.  
Foods, drugs, idiopathic causes and venom sting 
were the most common triggers. Milk, egg and wheat 
were the most causative foods in pediatrics but sesame, 
egg, milk and saffron were the most causative foods in 
adults. It was found that 62.5% of cases had more than 
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one attack. Food, idiopathic causes, drug and exercise 
were the most causative triggers in repeated 
anaphylaxis. Visiting an allergist and determining the 
cause could significantly decrease the rate of recurrent 
anaphylaxis; however, in the case of food, idiopathic 
and drug, repeated anaphylaxis occurred, despite 
documentation of the correct diagnosis and determining 
the etiology. Based on the guidelines epinephrine is the 
only permanent drug in anaphylaxis and a patient may 
meet anaphylaxis once in a life and could result in 
death or survive with a simple injection so it is critical 
to aware the role and importance of it in anaphylaxis. 
Epinephrine injection, auto-injection of epinephrine 
prescription and referral to an allergist were 
significantly low in our study, however this study was 
done in 3 centers and could not present the whole 
picture of anaphylaxis characteristics and management 
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